Paper1089999
Glucagon: role in the hyperglycemia of diabetes mellitus.
Dobbs R and 7 others. Science, 1975. Cited by 243 papers, by iCite.
Cite this record
ConductScience Library. Glucagon: role in the hyperglycemia of diabetes mellitus. Papers, record 1089999. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1089999
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus | Major topic |
| Glucagon | Major topic |
| Growth Hormone-Releasing Hormone | Major topic |
| Hyperglycemia | Major topic |
| Animals | |
| Arginine | |
| Diabetes Complications | |
| Diabetes Mellitus, Experimental | |
| Dogs | |
| Insulin | |
| Oligopeptides | |
| Pancreatectomy |
Source PubMed
Cited by73
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 243 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42651699 | For Weight Loss: Why Do GLP-1 Agonists Work, and How Can We Make Them Work Better? | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42651699 | PubMed |
| 41206016 | Glucagon, the Alpha Cell, and Potential Targets for Diabetes Treatment. | Endocrinology | 2025 | https://conductscience.org/library/papers/41206016 | PubMed |
| 40854221 | Glucagon Receptor Deficiency Causes Early-Onset Hepatic Steatosis. | Diabetes | 2025 | https://conductscience.org/library/papers/40854221 | PubMed |
| 37258572 | The YTHDC1/GLUT3/RNF183 axis forms a positive feedback loop that modulates glucose metabolism and bladder cancer progression. | Exp Mol Med | 2023 | https://conductscience.org/library/papers/37258572 | PubMed |
| 36729958 | A newly developed glucagon sandwich ELISA is useful for more accurate glucagon evaluation than the currently used sandwich ELISA in subjects with elevated plasma proglucagon-derived peptide levels. | J Diabetes Investig | 2023 | https://conductscience.org/library/papers/36729958 | PubMed |
| 35784565 | Role of Glucagon and Its Receptor in the Pathogenesis of Diabetes. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/35784565 | PubMed |
| 32259078 | Inventing Liraglutide, a Glucagon-Like Peptide-1 Analogue, for the Treatment of Diabetes and Obesity. | ACS Pharmacol Transl Sci | 2019 | https://conductscience.org/library/papers/32259078 | PubMed |
| 31967385 | Flavone Hispidulin Stimulates Glucagon-Like Peptide-1 Secretion and Ameliorates Hyperglycemia in Streptozotocin-Induced Diabetic Mice. | Mol Nutr Food Res | 2020 | https://conductscience.org/library/papers/31967385 | PubMed |
| 31936192 | Revisiting the Pharmacological Value of Glucagon: An Editorial for the Special Issue "The Biology and Pharmacology of Glucagon". | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/31936192 | PubMed |
| 30216981 | The Flavonoid Kaempferol Ameliorates Streptozotocin-Induced Diabetes by Suppressing Hepatic Glucose Production. | Molecules | 2018 | https://conductscience.org/library/papers/30216981 | PubMed |
| 29773871 | The somatostatin-secreting pancreatic δ-cell in health and disease. | Nat Rev Endocrinol | 2018 | https://conductscience.org/library/papers/29773871 | PubMed |
| 29438473 | In Uncontrolled Diabetes, Hyperglucagonemia and Ketosis Result From Deficient Leptin Action in the Parabrachial Nucleus. | Endocrinology | 2018 | https://conductscience.org/library/papers/29438473 | PubMed |
| 29322286 | Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression. | J Bioenerg Biomembr | 2018 | https://conductscience.org/library/papers/29322286 | PubMed |
| 28239611 | Pleotropic Acute and Chronic Effects of Leptin to Reverse Type 1 Diabetes. | Postdoc J | 2017 | https://conductscience.org/library/papers/28239611 | PubMed |
| 27901482 | Hyperglycemia triggers HIPK2 protein degradation. | Oncotarget | 2017 | https://conductscience.org/library/papers/27901482 | PubMed |
| 27362798 | ZnCl2 sustains the adriamycin-induced cell death inhibited by high glucose. | Cell Death Dis | 2016 | https://conductscience.org/library/papers/27362798 | PubMed |
| 27115412 | Glucagon is the key factor in the development of diabetes. | Diabetologia | 2016 | https://conductscience.org/library/papers/27115412 | PubMed |
| 26969486 | The role of leptin in diabetes: metabolic effects. | Diabetologia | 2016 | https://conductscience.org/library/papers/26969486 | PubMed |
| 25850661 | Islet α cells and glucagon--critical regulators of energy homeostasis. | Nat Rev Endocrinol | 2015 | https://conductscience.org/library/papers/25850661 | PubMed |
| 25633417 | Evidence That in Uncontrolled Diabetes, Hyperglucagonemia Is Required for Ketosis but Not for Increased Hepatic Glucose Production or Hyperglycemia. | Diabetes | 2015 | https://conductscience.org/library/papers/25633417 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1089999
GET https://conductscience.org/api/papers/v1/1089999/cited_by?page=2